JW Therapeutics 药明巨诺
James Li, currently the Co-Founder and CEO at JW Therapeutics, has an extensive background in the pharmaceutical industry. James previously held the position of Vice President and General Manager at Amgen and was a Partner at Kleiner Perkins Caufield & Byers. With experience as a Franchise Head at Merck and a strong educational background in both medicine and microbiology, James Li brings a wealth of knowledge and expertise to their current role.
This person is not in any teams
This person is not in any offices
JW Therapeutics 药明巨诺
JW Therapeutics is an innovative biotech company focusing on the latest clinical cell therapy technology. It is commited to the development, transformation and promotion of breakthrough cell-based immunotherapies to save the lives of cancer patients, improve their quality of life and bring new hope. JW Therapeutics was co-founded by WuXi AppTec, Juno Therapeutics in February 2016.